A detailed history of First Eagle Investment Management, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, First Eagle Investment Management, LLC holds 17,487 shares of EXEL stock, worth $579,694. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,487
Previous 15,887 10.07%
Holding current value
$579,694
Previous $356,000 27.25%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$21.96 - $27.6 $35,136 - $44,160
1,600 Added 10.07%
17,487 $453,000
Q2 2024

Aug 12, 2024

BUY
$20.34 - $23.73 $22,374 - $26,103
1,100 Added 7.44%
15,887 $356,000
Q1 2024

May 09, 2024

SELL
$20.17 - $23.93 $209,929 - $249,063
-10,408 Reduced 41.31%
14,787 $350,000
Q3 2023

Nov 08, 2023

BUY
$19.04 - $22.74 $479,712 - $572,934
25,195 New
25,195 $550,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track First Eagle Investment Management, LLC Portfolio

Follow First Eagle Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Eagle Investment Management, LLC with notifications on news.